Overview
Cybimed is a specialist retailer of in vitro diagnostic reagents and laboratory and medical equipment. Its products serve diagnostic laboratories, doctors’ offices, rehabilitation facilities and aesthetic medicine practices; the range includes analyzers, rapid tests and disinfectants.
- Monday–Friday
- 8:00–15:00
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 96 days early.
- 202520/04/2026
- 202428/03/2025
- 202302/04/2024
- 202220/04/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Laboratory analyzers
- Rapid diagnostic tests
- Diagnostic reagents
- Phototherapy equipment
- Disinfectants
Website technology
- Online shop
- S Shoper
- Analytics and marketing
- Google Tag Manager
Public procurement
No recorded participation in tenders.
Cybimed is the contractor in 6 public sector contracts, worth USD 2.89k in total. They were signed with 6 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 26, 2026 | Pain-relieving device | $1,216 | Wojewódzki Szpital Podkarpacki Im. Jana Pawła II w Krośnie | |
| Sep 16, 2026 | Supply of chemical reagents. | $131.13 | Gdański Uniwersytet Medyczny | |
| Aug 31, 2026 | Laboratory reagents | $133.44 | Uniwersytet Mikołaja Kopernika w Toruniu |
Trademarks
Cybimed holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2025.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| cybimed. | Z.594936 | 5, 9, 10, 35, 44 | Protected | Dec 6, 2035 | |
| CYBIMED(word) | Z.589002 | 5, 9, 10, 35, 44 | Protected | Aug 17, 2035 |
| Mark | Protected until | |
|---|---|---|
| cybimed. | Dec 6, 2035 | |
| CYBIMED(word) | Aug 17, 2035 |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, each member of the management board is independently authorized to submit declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Monika Frankowskaage 52 | 50 | $675.31 | 50% |
Kamil Arkadiusz Frankowskiage 51 | 50 | $675.31 | 50% |
Kamil Arkadiusz Frankowski and Monika Frankowska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-11-15.
19 1020 5011 0000 9102 0456 2981
31 1140 2004 0000 3003 0085 7527
88 1140 2004 0000 3202 8187 0011
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 30, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,650$1,650 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Red Med Polandsp. z o.o. | $2,508,628.68 | redmed.pl | ||
| Mikamedsp. z o.o. | $1,938,472.05 | mikamed.pl | ||
| In2labsp. z o.o. | $1,446,943.64 | in2lab.pl | ||
| Gin-Medicalsp. z o.o. | $1,315,440.45 | ginmedical.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Zbadajsiesp. z o.o. | $1,112,372.08 | labhome.pl | ||
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | ||
| Model MedicalS.A. | $754,014.76 | modelmedical.pl | ||
| Farmatorsp. z o.o. | $731,930.27 | farmator.eu | ||
| Medcellsp. z o.o. | $339,369.93 | medcell.pl |
FAQ
Last updated: 2026-04-20